Literature DB >> 11849703

Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor.

Phalgun B Joshi1, Ben L Kelly, Shaden Kamhawi, David L Sacks, W Robert McMaster.   

Abstract

Leishmanolysin, the Leishmania surface metalloproteinase of 63 kDa (GP63) has been described as a parasite virulence factor and is involved in the direct interaction of promastigotes and host macrophage receptors and interaction with the complement cascade. To study the role of leishmanolysin in the pathogenesis and virulence of Leishmania major, targeted gene replacement was used to delete the entire 20 kb region containing all seven leishmanolysin genes (gp63 genes 1-7). The resulting L. major leishmanolysin deficient mutants showed normal development inside the sand fly vector, however, promastigotes recovered from sand flies or from culture showed an increase in sensitivity to complement-mediated lysis and a delay in lesion formation in BALB/c animals. The phenotypic differences could be significantly improved by expression of a cloned leishmanolysin gene. These results demonstrate that leishmanolysin is a vital virulence factor in Leishmania pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849703     DOI: 10.1016/s0166-6851(01)00432-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  98 in total

1.  Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity.

Authors:  A K Marr; S Cen; R E W Hancock; W R McMaster
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 2.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Episomally driven antisense mRNA abrogates the hyperinducible expression and function of a unique cell surface class I nuclease in the primitive trypanosomatid parasite, Crithidia luciliae.

Authors:  Mat Yamage; Manju B Joshi; Dennis M Dwyer
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

Review 4.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

5.  Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Authors:  Anne Maurer-Cecchini; Saskia Decuypere; François Chappuis; Coralie Alexandrenne; Simonne De Doncker; Marleen Boelaert; Jean-Claude Dujardin; Louis Loutan; Jean-Michel Dayer; Gianfranco Tulliano; Jorge Arevalo; Alexandro Llanos-Cuentas; Carlo Chizzolini
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

6.  Gene identification and comparative molecular modeling of a Trypanosoma rangeli major surface protease.

Authors:  Paulo H M Calixto; Mainá Bitar; Keila A M Ferreira; Odonírio Abrahão; Eliane Lages-Silva; Glória R Franco; Luis E Ramírez; André L Pedrosa
Journal:  J Mol Model       Date:  2013-04-13       Impact factor: 1.810

7.  Design of protease-resistant pexiganan enhances antileishmanial activity.

Authors:  Manjusha M Kulkarni; Anna Karafova; Wojciech Kamysz; Bradford S McGwire
Journal:  Parasitol Res       Date:  2014-05       Impact factor: 2.289

8.  The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts.

Authors:  Gerald F Späth; L A Garraway; Salvatore J Turco; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

9.  Characterization of a subunit of the outer dynein arm docking complex necessary for correct flagellar assembly in Leishmania donovani.

Authors:  Simone Harder; Meike Thiel; Joachim Clos; Iris Bruchhaus
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

10.  Insights from the analysis of a predicted model of gp63 in Leishmania donovani.

Authors:  Ali Razzazan; Mohammad Reza Saberi; Mahmoud Reza Jaafari
Journal:  Bioinformation       Date:  2008-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.